ORLISTAT POLPHARMA 120mg capsules medication leaflet

Indicated for: obesity; weight management

Substance: orlistat (enzyme inhibitor)

ATC: A08AB01 (Alimentary tract and metabolism | Antiobesity preparations, excl. diet products | Peripherally acting antiobesity products)

Orlistat is a medication used for the treatment of obesity, acting by inhibiting gastrointestinal lipases, enzymes that break down fats in food. As a result, some fats are not absorbed and are eliminated in the stool.

The medication is taken orally, usually during main meals, as directed by your doctor. It is important to combine the treatment with a low-calorie, balanced diet to achieve the best results.

Side effects may include abdominal discomfort, flatulence, oily stools, or, in rare cases, deficiencies in fat-soluble vitamins.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as malabsorption syndrome, to ensure the safe use of orlistat.

General data about ORLISTAT POLPHARMA 120mg

  • Substance: orlistat
  • Date of last drug list: 01-07-2013
  • Commercial code: W58053001
  • Concentration: 120mg
  • Pharmaceutical form: capsules
  • Quantity: 21
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Concentrations available for orlistat

120mg, 60mg